This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Christoph Ullmer: Innovator in Antibody Development
Introduction
Christoph Ullmer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Ullmer holds a patent for an antibody that binds to VEGF-A and ANG2, along with methods of use. This invention relates to anti-VEGF-A/anti-ANG2 antibodies, specifically in the form of a bispecific Fab fragment. The methods of using these antibodies have the potential to advance therapeutic approaches in treating various diseases.
Career Highlights
Throughout his career, Christoph Ullmer has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG, where he has contributed to groundbreaking research and development projects.
Collaborations
Ullmer has collaborated with esteemed colleagues, including Roland Beckmann and Sebastian Fenn. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in the field of biotechnology.
Conclusion
Christoph Ullmer's contributions to antibody development and his innovative patent highlight his role as a key figure in biotechnology. His work continues to influence the industry and pave the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile